Nuvig was founded by Pamela Conley.

Who are Nuvig's investors?

Nuvig's investors include B Capital Group, B4 Capital, Global BioAccess Fund, Mission Biocapital, Sanofi Ventures, Digitalis Ventures, Norwest Venture Partners.

How much funding has Nuvig raised?

Nuvig has disclosed $161M raised across 1 round.

Nuvig

22 employees on LinkedIn · 7 known investors

Find your way into Nuvig

Paths you didn't know you had: your email and LinkedIn already hold routes to the Nuvig team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.

Biotech Healthtech Medical Devices

Founders & leadership

Pamela Conley Chief Scientific Officer and Co-founderPamela Conley holds a Ph.D. and has more than 25 years of experience in drug discovery and development, with expertise in small molecule and biologic therapeutics across cardiovascular disease, inflammation, and hematologic malignancies. She has led target identification and validation, clinical development, and regulatory submissions for multiple investigational new drugs.

Investors · 7

B Capital Grouplisted by B Capital GroupSan Francisco · $10M – $50M

How we know: B Capital Group's portfolio page · the VCSheet dataset · Not right? Tell us

B4 Capitallisted by B4 Capital$10M – $50M

Global BioAccess Fundlisted by Global BioAccess FundNew York · $10M

Mission Biocapitallisted by Mission BiocapitalSan Francisco · $500K

How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us

Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M

How we know: Sanofi Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us

Digitalis VenturesreportedNew York · $100K – $10M

How we know: the VCSheet dataset · Not right? Tell us

Norwest Venture PartnersreportedMenlo Park · $10M – $30M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$161M disclosed across 1 round · 2024

$161MraisedDec 2024 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Nuvig Therapeutics Raises $161M in Series B Fundingfinsmes.com · Dec 2024

Frequently asked questions

What does Nuvig do?: Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.
Who founded Nuvig?: Nuvig was founded by Pamela Conley.
Who are Nuvig's investors?: Nuvig's investors include B Capital Group, B4 Capital, Global BioAccess Fund, Mission Biocapital, Sanofi Ventures, Digitalis Ventures, Norwest Venture Partners.
How much funding has Nuvig raised?: Nuvig has disclosed $161M raised across 1 round.